Nicola Gambacorta

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Molecular Dynamics Simulations

Structural Basis

Respiratory Syndrome Coronavirus

Top Venues

Journal of clinical medicine

Molecules (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Francesco Samarelli, Giovanni Graziano, Nicola Gambacorta, Elisabetta Anna Graps, Francesco Leonetti, Nicolotti Orazio, Cosimo Damiano Altomare
Small Molecules for the Treatment of Long-COVID-Related Vascular Damage and Abnormal Blood Clotting: A Patent-Based Appraisal. Viruses 16 (3) (2024)
Francesco Samarelli, Giovanni Graziano, Nicola Gambacorta, Elisabetta Anna Graps, Francesco Leonetti, Nicolotti Orazio, Cosimo Damiano Altomare
Small Molecules for the Treatment of Long-COVID-Related Vascular Damage and Abnormal Blood Clotting: A Patent-Based Appraisal. Viruses 16 (3) (2024)
Francesco Samarelli, Giovanni Graziano, Nicola Gambacorta, Elisabetta Anna Graps, Francesco Leonetti, Nicolotti Orazio, Cosimo Damiano Altomare
Small Molecules for the Treatment of Long-COVID-Related Vascular Damage and Abnormal Blood Clotting: A Patent-Based Appraisal. Viruses 16 (3) (2024)
Francesco Samarelli, Giovanni Graziano, Nicola Gambacorta, Elisabetta Anna Graps, Francesco Leonetti, Nicolotti Orazio, Cosimo Damiano Altomare
Small Molecules for the Treatment of Long-COVID-Related Vascular Damage and Abnormal Blood Clotting: A Patent-Based Appraisal. Viruses 16 (3) (2024)
Daniela Valeria Miniero, Nicola Gambacorta, Anna Spagnoletta, Vincenzo Tragni, Stefano Loizzo, Nicolotti Orazio, Ciro Leonardo Pierri, Annalisa De Palma
New Insights Regarding Hemin Inhibition of the Purified Rat Brain 2-Oxoglutarate Carrier and Relationships with Mitochondrial Dysfunction. Journal of clinical medicine 11 (24) (2022)
Daniela Valeria Miniero, Nicola Gambacorta, Anna Spagnoletta, Vincenzo Tragni, Stefano Loizzo, Nicolotti Orazio, Ciro Leonardo Pierri, Annalisa De Palma
New Insights Regarding Hemin Inhibition of the Purified Rat Brain 2-Oxoglutarate Carrier and Relationships with Mitochondrial Dysfunction. Journal of clinical medicine 11 (24) (2022)
Fulvio Ciriaco, Nicola Gambacorta, Daniela Trisciuzzi, Nicolotti Orazio
PLATO: A Predictive Drug Discovery Web Platform for Efficient Target Fishing and Bioactivity Profiling of Small Molecules. International journal of molecular sciences 23 (9) (2022)
Nisha Abdul Rehuman, Jong Min Oh, Mohamed Abdelwahab Abdelgawad, Eman A M Beshr, Mohammad A S Abourehab, Nicola Gambacorta, Nicolotti Orazio, Rakesh Kumar Jat, Hoon Kim, Bijo Mathew
Development of Halogenated-Chalcones Bearing with Dimethoxy Phenyl Head as Monoamine Oxidase-B Inhibitors. Pharmaceuticals (Basel, Switzerland) 15 (9) (2022)
Nicola Gambacorta, Leonardo Caputo, Laura Quintieri, Linda Monaci, Fulvio Ciriaco, Nicolotti Orazio
Rational Discovery of Antiviral Whey Protein-Derived Small Peptides Targeting the SARS-CoV-2 Main Protease. Biomedicines 10 (5) (2022)
Daniela Valeria Miniero, Nicola Gambacorta, Anna Spagnoletta, Vincenzo Tragni, Stefano Loizzo, Nicolotti Orazio, Ciro Leonardo Pierri, Annalisa De Palma
New Insights Regarding Hemin Inhibition of the Purified Rat Brain 2-Oxoglutarate Carrier and Relationships with Mitochondrial Dysfunction. Journal of clinical medicine 11 (24) (2022)
Daniela Valeria Miniero, Nicola Gambacorta, Anna Spagnoletta, Vincenzo Tragni, Stefano Loizzo, Nicolotti Orazio, Ciro Leonardo Pierri, Annalisa De Palma
New Insights Regarding Hemin Inhibition of the Purified Rat Brain 2-Oxoglutarate Carrier and Relationships with Mitochondrial Dysfunction. Journal of clinical medicine 11 (24) (2022)
Mehmet Abdullah Alagöz, Jong Min Oh, Yaren Nur Zenni, Zeynep Özdemir, Mohamed Abdelwahab Abdelgawad, Ibrahim A Naguib, Mohammed M Ghoneim, Nicola Gambacorta, Nicolotti Orazio, Hoon Kim, Bijo Mathew
Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors. Molecules (Basel, Switzerland) 27 (12) (2022)
Rosa Purgatorio, Nicola Gambacorta, Francesco Samarelli, Gianfranco Lopopolo, Modesto de Candia, Marco Catto, Nicolotti Orazio, Cosimo Damiano Altomare
Assessing the Role of a Malonamide Linker in the Design of Potent Dual Inhibitors of Factor Xa and Cholinesterases. Molecules (Basel, Switzerland) 27 (13) (2022)
Marialuigia Fantacuzzi, Marialucia Gallorini, Nicola Gambacorta, Alessandra Ammazzalorso, Zeineb Aturki, Marwa Balaha, Simone Carradori, Letizia Giampietro, Cristina Maccallini, Amelia Cataldi, Nicolotti Orazio, Rosa Amoroso, Barbara De Filippis
Design, Synthesis and Biological Evaluation of Aromatase Inhibitors Based on Sulfonates and Sulfonamides of Resveratrol. Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Rosa Purgatorio, Nicola Gambacorta, Modesto de Candia, Marco Catto, Mariagrazia Rullo, Leonardo Pisani, Nicolotti Orazio, Cosimo Damiano Altomare
First-in-Class Isonipecotamide-Based Thrombin and Cholinesterase Dual Inhibitors with Potential for Alzheimer Disease. Molecules (Basel, Switzerland) 26 (17) (2021)
Daniela Valeria Miniero, Anna Spagnoletta, Nicola Gambacorta, Vito Scalera, Ciro Leonardo Pierri, Nicolotti Orazio, Annalisa De Palma
The Interaction of Hemin, a Porphyrin Derivative, with the Purified Rat Brain 2-Oxoglutarate Carrier. Biomolecules 11 (8) (2021)
Anusree Venkidath, Jong Min Oh, Sanal Dev, Elham Amin, Shebina P Rasheed, Ajeesh Vengamthodi, Nicola Gambacorta, Ahmed Khames, Mohamed Abdelwahab Abdelgawad, Ginson George, Nicolotti Orazio, Hoon Kim, Bijo Mathew
Selected Class of Enamides Bearing Nitro Functionality as Dual-Acting with Highly Selective Monoamine Oxidase-B and BACE1 Inhibitors. Molecules (Basel, Switzerland) 26 (19) (2021)